Aurora SpineTSXV:ASG 41 Net Margin % is -4.58% as of Mar. 2026. GuruFocus rates TSXV:ASG with a GF Score™ of 41/100 and a GF Value™ of C$0.32 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 817 Medical Devices & Instruments companies, Aurora Spine ranks worse than 58.02% on this metric.
Net margin is calculated as Net Income divided by its Revenue. Aurora Spine's Net Income for the
three
months ended in Mar. 2026 was C$-0.28 Mil. Aurora Spine's Revenue for the
three
months ended in Mar. 2026 was C$6.09 Mil. Therefore, Aurora Spine's net margin for the quarter that ended in Mar. 2026 was -4.58%.
The historical rank and industry rank for Aurora Spine's Net Margin % or its related term are showing as below:
TSXV:ASG'
s Net Margin % Range Over the Past 10 Years
Min: -37.4 Med: -10.67 Max: -0.78
Current: -3.18
TSXV:ASG's Net Margin % is ranked worse than 58.02% of 817
companies
in the Medical Devices & Instruments industry
Industry Median: 2.07
vs TSXV:ASG: -3.18
Aurora Spine (TSXV:ASG) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Aurora Spine Net Margin % Related Terms
Aurora Spine Net Margin % Historical Data
* Premium members only.
The historical data trend for Aurora Spine's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSXV:ASG vs ABT, SYK, MDT: Net Margin % Comparison
For the Medical Devices subindustry, Aurora Spine's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aurora Spine Net Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Aurora Spine's Net Margin % distribution charts can be found below:
* The bar in red indicates where Aurora Spine's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Aurora Spine (TSXV:ASG) has a Net Margin % of -4.58% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on Aurora Spine and its competitors. According to the industry distribution chart, Aurora Spine ranks #474 out of 817 companies in the Medical Devices & Instruments industry, placing it in the top 58%.
Is Aurora Spine's Net Margin % too high?
Aurora Spine's current Net Margin % is -4.58%. Based on the distribution chart, Aurora Spine ranks #474 out of 817 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Aurora Spine has a GF Score™ of 41/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Aurora Spine's Net Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Aurora Spine ranks #474 out of 817 companies for Net Margin %. This places Aurora Spine in the lower half of its industry. The industry median Net Margin % is 2.07. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Medical Devices & Instruments company?
The median Net Margin % among Medical Devices & Instruments companies is 2.07, based on 817 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Aurora Spine and its competitors. For the Medical Devices & Instruments industry, the median Net Margin % is 2.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aurora Spine's current Net Margin % is -4.58%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aurora Spine stock overvalued right now?
Based on GuruFocus' analysis, Aurora Spine (TSXV:ASG) is currently considered Modestly Undervalued. The stock's GF Value™ is C$0.32, compared to a current price of C$0.23 — trading 28.1% below its estimated fair value. The current Net Margin % is -4.58%. Aurora Spine's overall GF Score™ is 41/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Aurora Spine (TSXV:ASG), the current Net Margin % is -4.58% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Aurora Spine (TSXV:ASG) Overvalued in 2026?
Based on GuruFocus' analysis, Aurora Spine stock appears to be undervalued.
The current stock price of C$0.23 is trading 28.1% below its estimated GF Value™ of C$0.32.
GuruFocus considers Aurora Spine to be Modestly Undervalued.
Key valuation signals for TSXV:ASG:
Net Margin %: -4.58%
GF Value™: C$0.32 vs. price of C$0.23 (28.1% below fair value)
No single metric tells the full story. See the TSXV:ASG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Aurora Spine Corp is engaged in the development, manufacture, and sale of minimally invasive, interspinous fusion systems and devices. These 510K and patent protected medical devices improve patient outcomes in the area of spine and sacroiliac joint surgical procedures. The company is focused on bringing new solutions to the spinal implant market through a series of minimally invasive, regenerative spinal implant technologies.
41GF Score
Get the complete analysis for TSXV:ASG
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSXV:ASG has been successfully added to your 
